Division of Gastroenterology and Hepatology, University of Wisconsin School of Medicine and Public Health, Madison, WI, USA.
Liver Int. 2017 Mar;37(3):343-344. doi: 10.1111/liv.13343.
Although liver transplantation has become accepted as a life-saving treatment of last resort for most life-threatening liver disorders, the use of liver transplantation to rescue patients with severe alcoholic hepatitis unresponsive to medical therapy remains controversial. I propose the concepts that alcohol use disorder is an illness, that on occasion results in alcoholic liver disease and that treatment of alcoholic liver disease, including treatment of patients with severe alcoholic hepatitis, combines treatment of the alcohol use disorder and of alcoholic liver disease. From this I derive the following principal to govern selection of patients for liver transplantation of patients with alcohol use disorder: that alcohol use disorder should impact suitability for liver transplantation as a co-morbid disorder, in the same way as other common co-morbid disorders such as diabetes mellitus or systemic hypertension, are factored in the selection process. We should relate the risk of drinking relapse to the prognosis of the patient after transplantation, rather than in a binary construct of likelihood of maintaining abstinence vs drinking.
虽然肝移植已被接受为大多数危及生命的肝脏疾病的救命治疗方法,但使用肝移植来抢救对药物治疗无反应的重症酒精性肝炎患者仍存在争议。我提出的概念是,酒精使用障碍是一种疾病,有时会导致酒精性肝病,而酒精性肝病的治疗,包括重症酒精性肝炎患者的治疗,结合了酒精使用障碍和酒精性肝病的治疗。由此,我得出了以下原则,用于指导患有酒精使用障碍的患者进行肝移植的选择:酒精使用障碍应该作为一种合并症影响肝移植的适宜性,就像其他常见的合并症如糖尿病或系统性高血压一样,在选择过程中被考虑进去。我们应该将饮酒复发的风险与患者移植后的预后联系起来,而不是在是否能保持戒酒的二分法结构中进行评估。